Clinical trial
Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients…
NCT00212017 · National Cerebral and Cardiovascular Center, Japan, Other · Terminated
Key facts
| NCT number | NCT00212017 |
|---|---|
| Title | Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGT |
| Official title | The Japan Working Group for the Assessment That the Alpha-glucosidase Inhibitor Blocks Cardiac Events in Patients With Myocardial Infarction and IGT |
| Lead sponsor | National Cerebral and Cardiovascular Center, Japan, Other |
| Collaborators | Ministry of Health, Labor and Welfare (Japan) |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Impaired Glucose Tolerance, Myocardial Infarction |
| Intervention type | Behavioral, Drug |
| Interventions | voglibose, diet and exercise therapy |
| Enrollment | 3,000 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2012 |
| Completion | Aug 1, 2017 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 22, 2018 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: